Bilateral Male Breast Cancer and Prostate Cancer: A Case Report (original) (raw)
Related papers
Bilateral synchronous male breast cancer
SAUDI MEDICAL JOURNAL, 2015
لدى وجد للغاية. ٌ نادرا مرض هو الثنائي املتزامن الثدي سرطان من والذي األمين، الثدي في كتلة ً عاما 75 العمر من يبلغ رجل األمين الثدي فحص وكشف األيسر. الثدي في تورم وجود املتوقع للخارج مقلوبة حواف مع 7x10cm الثدي في قرحة وجود من الصعب من كتل األيسر الثدي أظهر بالكامل. مدمرة وحلمة على مرتبط غير للحلمة، الهللية منطقة في 4x5cm قياسها إبطية ليمفاوية عقدة هناك يكن لم التحتية. البنية أو اجللد، قرحة اليمني من إسفني خزعة أكدت اجلانبني. كال في مجسوسة األقنية سرطان الغازية الثنائي األيسر الثدي ورم واستئصال الثدي استئصال له أجري و الثديني. كال في 2 الصنف من الورم في -شهرا 18 ملدة وتعثر الكيميائي. والعالج للثدي الثنائي بسيط هو التقرير هذا أهمية إن الثنائي. الورم وعاد العالج، فترة خالل للذكور يحدث أن ميكن الثدي سرطان بأن الوعي من املزيد لنشر أمر للذكور حدوثه أن من الرغم على اإلناث، في فقط وليس أفضل. نتائج العالج ومتابعة املبكر التشخيص يوفر نادر. Bilateral synchronous breast cancer is extremely rare. A 75-year-old man presented with a right breast mass, which ulcerated and a lump in the left breast. Right breast examination revealed a breast ulcer 7x10cm with everted edges and complete nipple destruction.
Synchronous bilateral breast cancer in men: a case report and review of the literature
Tumori
Breast carcinoma is a rare disease in men, and bilateral cases are extremely uncommon. The rarity of male breast carcinoma and the small number of large studies on this topic have made it necessary to extrapolate treatment standards and outcomes from those established for women. Between 1997 and 2007, 75 men with breast cancer were referred to our institute, and the bilateral case we present here was the only one we have observed since 1994. The goal of our work was to contribute to the available literature with this extremely unusual presentation of the disease.
Case Reports in Oncology, 2021
Prostate cancer is common in men, but tumour of the male breast is rare. For these two tumours to be presented synchronously in a male patient is even rarer. The focus of this paper is the case of a 72-year-old man diagnosed with papillary ductal carcinoma in situ after he presented with a unilateral breast mass associated with nipple discharge. Imaging staging for his breast tumour and subsequent prostate biopsy found an incidental synchronous asymptomatic prostate adenocarcinoma as well as bone metastases. He denies risk factors for malignancies and refuses genetic testing. The first part of our discussion will highlight the uncommon occurrence of male breast ductal carcinoma in situ and its management controversies. The subsequent part of our discussion will focus on the association between male breast cancer and prostate cancer, and implication of this on the future treatment of these patients. More importantly, our case will illustrate the challenges in managing dual primaries ...
A Rare Case of Bilateral Synchronous Male Breast Cancer: A Multimodality Approach
European Journal of Breast Health, 2022
Points • Mammography is the first-line method and is highly sensitive and specific for breast cancer in males, similar to female breast cancer. • Magnetic resonance imaging can be used successfully in the assessment of the male breast and its use should be recommended, especially in cases where initial imaging is indeterminate. • Increasing awareness of male breast cancer will prevent delays in diagnosis and treatment.
Second primary malignancies in patients with male breast cancer
2005
An international multicentre study of first and second primary neoplasms associated with male breast cancer was carried out by pooling data from 13 cancer registries. Among a total of 3409 men with primary breast cancer, 426 (12.5%) developed a second neoplasia; other than breast cancer, a 34% overall excess risk of second primary neoplasia, affecting the small intestine (standardised
Indian Journal of Surgery, 2010
Male breast cancer is an uncommon disease. The incidence of male breast cancer has been found to be gradually but steadily increasing. However, because of rarity of this disease, it is not exhaustively studied and discussed when compared to the female counterpart. The occurrence of a contralateral breast cancer in a male is much rarer. We are reporting a case of contralateral male breast cancer with a positive family history. This is an uncommonly reported entity. The relevant literature has been reviewed and a brief discussion on the current concepts on male breast cancer has been added.
Male Breast Cancer: A Rare Entity
Journal of Nepal Medical Association, 2018
Male breast carcinoma is a rare malignancy (<1% of all breast carcinomas, 0.2% of all male malignancies). Its common histopathological type is infiltrating carcinoma, not otherwise specified. Three male patients aged 56 (stage -IIIB), 64 (T4bN0M0) and 78 (T2N0MO) years presented with a breast lump within a year. Their hematological and biochemical parameters were within normal limits. Two of them had palpable regional lymph nodes. Male breast carcinoma occurs in older males as in our cases. Two cases showed infiltrating ductal carcinoma, not otherwise specified on histopathological evaluation, and one showed special type with apocrine differentiation. Their two-year follow-up was uneventful after modified radical mastectomy and chemotherapy. Male breast carcinoma is associated with risk factors different from and overlapping with female breast carcinoma. Male breast carcinoma differs from female breast carcinoma on clinical presentation, biological behaviour and prognosis. Male b...
Bilateral Breast Cancer in a 65-Year-Old Man
Globally, breast cancer in men is exceedingly uncommon. The misinterpretation of signs and symptoms and lack of a proper medical history can lead to the progression of rare conditions to advanced stages. We report the case of a 65year-old man who presented to the clinic complaining about progressive bilateral dull breast pain. He had been diagnosed with bilateral grade II invasive ductal carcinoma three months prior, and he underwent bilateral mastectomy followed by chemotherapy as a part of his treatment plan.